54 results about "Central venous pressure" patented technology

Photoplethysmography (PPG) is obtained using one red (e.g., 660 nm) and one infrared (e.g., 880 to 940 nm) light emitting diode with a single photo diode in combination with a pressure transducer thereby allowing both CVP and SpO2 to be measured simultaneously. The system also includes sensors capable of measuring position, angle and/or movement of the sensor or patient. Once the PPG signal is acquired, high pass adaptive and/or notch filtering can be used with one element of the filter from the red and infrared signals used to measure the arterial changes needed to compute SpO2 and the other element of the signal can be used to measure CVP changes.

Central Venous Pressure (CVP) is non-invasively determined with accuracy comparable to invasive measurement techniques. To do so, curves are plotted based on non-invasively determined patient information obtained by applying a controllable variable (pressure) to a vein of interest at a non-distal point and taking certain measurements (such as pressure and volume measurements) from the patient. An example of a controllable variable is voltage applied in incremental inflation/deflation of a vascular cuff (1). A curve is plotted based on datapoints (such as a volume increase curve or a volume decline curve). Pertinent, accurate CVP and/or blood volume information is obtained from the slope of the non-invasive-based curve. Accurate CVP information is provided without the risks and disadvantages of invasive measurements.

An implantable system for monitoring a hydration state of a patient and adjusting fluid removal from the patient includes a pressure sensor implantable within an inferior vena cava of the patient and a processor. The pressure sensor senses and generates an output representative of a baseline inferior vena caval pressure value of the patient and chronically senses and generates outputs representative of an inferior vena caval pressure value of the patient. The processor compares differences between the baseline inferior vena caval pressure value and subsequent inferior vena caval pressure values. The processor can reside in another implantable device or in an external device/system.

An instrument for at least estimating physiologic pressure such as central venous pressure (CVP) non-invasively includes an ultrasound probe coupled to a display that shows the deformation of a vein as pressure is applied outside the body through the skin and soft tissues. A pressure transducer is applied to the skin to compress a vein, and an indicator coupled to the transducer shows the amount of pressure being applied when the ultrasound probe shows that the vein has collapsed. In the preferred embodiment, the transducer is an inelastic balloon filled with a liquid such as water, and the indicator is in fluid communication with the balloon. The indicator may be a mechanical gauge or meter, or may include a material that converts applied pressure to an electrical signal, in which case the electrical signal may be interfaced to a numerical readout. At least the probe and the transducer are preferably disposed in a hand-held housing.

An arterially measured pressure signal is continuously read in and temporarily stored in the working memory (RAM). The function p(t) is processed by the central processing unit (CPU), to calculate the heart/time volume PCCO and other hemodynamic parameters. The calculation comprises the following steps: The systemic vascular resistance SVR_k is calculated for the current pulse period. The stroke volume SV_k is numerically determined from the pressure values of a pulse period, according to the following equation: ${\mathrm{SV}}_k\propto \sum \left(\frac{p_i\left(t\right)}{{\mathrm{SVR}}_k}+C_k\left(p_i\right)\frac{d{p}_i}{dt}\right)$

with the compliance C(p)=(MAP−CVP)_k/[SVR·<dp/dt>_k]·f(p). The difference between the mean arterial pressure MAP and the central venous pressure CVP, and the mean incline of the pressure curve in the diastole <dp/dt>, are re-determined for the current pulse period. The heart/time volume calculated in the current pulse period results from PCCO_k=SV_k·HR. Therefore, continuous recalibration of the systemic vascular resistance and of the compliance takes place, from the continuously determined pressure measurement data.

In one aspect, an apparatus for measuring peripheral venous pressure includes a tubing having two ends with one end connectable to a fluid source and the other end connectable to a vein, a fluid controlling device configured to have an on position and an off position, and at least one pressure sensor configured to measure fluid pressures therein. When the fluid controlling device is in the on position, fluid flow in the tubing is allowed to pass through the fluid controlling device, such that the at least one pressure sensor measures both a fluid pressure from the fluid source and a distal venous pressure from the vein. When the fluid controlling device is in the off position, no fluid flow in the tubing is allowed to pass through the fluid controlling device, such that the at least one pressure sensor measures the distal venous pressure from the vein only.

The invention discloses application of penehyclidine hydrochloride in preparation of a medicine for treating a hemorrhagic shock disease. Hemorrhagic shock has a pathological change that the central venous pressure, the peripheral mean arterial pressure and the cardiac output are all obviously reduced and the middle-light microcirculatory disturbance appears, the medicine for treating the hemorrhagic shock disease can be liquid and can also be solid, and the mass percent concentration of the penehyclidine hydrochloride in the medicine is between 0.01 and 2 percent. The application effect is proved through the influence of a penehyclidine hydrochloride water solution on a canine hemorrhagic shock model.

Techniques for pacing the heart of a patient as a function of a pressure value make use of a pressure monitor that receives a signal from a pressure sensor in the heart. The pressure monitor measures a pressure value. The pressure monitor may, for example, estimate the pulmonary artery diastolic pressure if the pressure sensor is located in the right ventricle, or calculate the mean central venous pressure if pressure sensor is located in the right atrium. The energy level of the pacing pulses delivered to the patient's heart by a pacemaker is modulated as a function of the pressure value. Modulating the energy level of the pacing pulses modulates the cardiac output of the patient's heart.

A system comprising a multi-sensor catheter for monitoring of a cardiac hemodynamic condition, e.g. heart failure, is disclosed. The multi-sensor catheter comprises multi-lumen catheter tubing comprising first and second optical pressure sensors, and their respective optical fibers and connectors. For right heart and pulmonary artery catheterization, a flow-directed multi-sensor catheter comprises a guidewire lumen, an inflatable balloon tip, and sensor locations are configured for placement of a sensor in each of the right atrium and pulmonary artery, for measurement of central venous pressure in the right atrium and a pulmonary artery pressure. An optical fiber for oximetry may be included. The outside diameter is small enough for insertion through a vein of the arm. For monitoring of a left atrial shunt, sensors of a multi-sensor catheter are configured for measuring pressures upstream and downstream of the shunt, e.g. in the left and right atria, or left atrium and coronary sinus.

A device for non-invasively measuring at least one parameter of a cardiac blood vessel in a patient comprises at least one light source that directs light at a tissue site on the patient; at least one photodetector adapted to receive light emitted by the light source and generate an output based on the received light, the output of said photodetector being correlated with a parameter of the blood vessel; and at least one probe for facilitating delivery of light from the light source to the tissue site, and receipt of light by the photodetector. The device may include a height sensor to adapt it for use to determine central venous pressure, or the configuration of light source(s) and photodetector(s) may be adapted to permit the device to provide attenuation correction in the determination of venous blood oxygenation.

A system for measuring central venous pressure is provided comprising a device for measuring jugular venous pressure in communication with a patient inclination controller via a processing unit.

Mean Pulmonary Arterial Pressure (MPAP), Mean Pulmonary Capillary Wedge Pressure (MPCWP) and Cardiac Index are all determinable (in a method or employing apparatus) from Central Venous Pressure (CVP), Mean Arterial Pressure (MAP), Heart Rate (HR), and Core Body Temperature (T) from the following relationships: MPAP=(a×MAP)+CVP (for MAP<58), or Va; MPAP=(a×MPAP)+CVP−(10×INT[(MAX {MAP−109), (CVP−7),0})/10]) for MAP>58); Vb; MPCWP=(b×MPAP)+CVP−(10×INT [CVP−7/10]; and VI; CI=K (T.CVP)/HR2, VII; where a and b are about 0.15; MAX (x, y, z)=largest of the three terms x, y, and z; INT [x]=integer part of x; MAP and CVP is measured in mmHg; T in Celsius and HR in counts per minute; CI is liters per square meter per minute; and K is a variable constant whose value is between 0 and 1000 depending on the values of CVP and HR.

A low cost, transportable system for monitoring the central venous pressure of a patient receiving an infusion is provided. The pressure monitoring system of the present invention employs a pump and a flow meter in order to supply infusion fluids to a patient. Based upon the control factors and changes thereof communicated to the pump by a controller in order to achieve and maintain a desired infusion fluid flow rate, relative changes in patient's venous pressure and/or quantitative pressure data is obtained.

A respiratory monitoring apparatus (10) includes a central venous pressure sensor (24) configured to measure a central venous pressure (CVP) signal of a patient. At least one processor (32, 34, 36, 38, 40, 42, 44, 58) is programmed to process the CVP signal to generate respiratory information for the patient by operations including: segmenting the CVP signal based on detected breath intervals; calculating a surrogate muscle pressure signal from the segmented CVP signal; and filtering the surrogate muscle pressure signal to remove a cardiac activity component a cardiac activity component of the surrogate respiratory muscle pressure signal.

The invention mainly discloses an infusion support capable of measuring central venous pressure. The infusion support comprises a supporting rod, universal wheels arranged on the bottom of the supporting rod and a hanging frame arranged at the top end of the supporting rod. A sliding groove and a horizontal telescopic sleeve rod capable of sliding along the sliding groove are arranged on the supporting rod in the length direction of the supporting rod, a measuring hammer is hung on the horizontal telescopic sleeve rod through a hook, the measuring hammer comprises a measuring plate, a hanging hole connected with the hook is formed in one end of the measuring plate, a gravity hammer is connected to the other end of the measuring plate, a clamping groove used for clamping an infusion tube is formed in the measuring plate in the direction from the center of the hanging hole to the center of the gravity hammer, scales used for measuring venous pressure values are arranged on the side of the clamping groove, and fixing clips for fixing the infusion tube are arranged at the two ends of the clamping groove. The infusion support can measure the central venous pressure of a patient accurately, operation is simple, convenient and fast, working difficulty of nursing staff is lowered, and accurate treatment of the patient is guaranteed.

The invention discloses a system for monitoring ARDS development of patients. The system comprises a master micro controller unit (MCU), wherein the master micro controller unit (MCU) is separately connected to data interfaces of a mechanical ventilation-respiratory mechanics monitoring module, a pulse index continuous cardiac output monitoring module, a central venous pressure and pulmonary artery pressure monitoring module, an oxygen metabolism dynamic monitoring module, a fibreoptic bronchoscopy module, an end-tidal carbon dioxide monitoring module and a broncholveolr lvge fluid and pulmonary tissue pathological examination module through bidirectional buses; an output end of the master micro controller unit (MCU) is also connected to an input end of a critical degree judgment module; the output end of the critical degree judgment module is also connected to the input end of a communication module; and the output end of the communication module is connected to the input end of a center console. According to the system, real-time monitoring data can be acquired, so that comprehensive examination of the patients is facilitated, differential diagnosis of an ARDS and multiple diseases is facilitated, and meanwhile, level judgment is more conducive to follow-up treatment on different patients.